Investigation of M. tuberculosis Cytochrome P450 Involvement in Cholesterol Utilization |
|
Department of Pharmaceutical Chemistry |
|
|
Characterizing Natural Product Permeability and Bioactivity |
|
Department of Pharmaceutical Chemistry |
|
|
Defining the Molecular-Cellular-Field Continuum of Mercury Detoxification |
|
Department of Pharmaceutical Chemistry |
|
|
Small Angle X-Ray and Neutron Scattering Studies of MER Enzymes |
|
Department of Pharmaceutical Chemistry |
|
|
Molecular Mechanisms of Bacterial Mercury Transformation |
|
Department of Pharmaceutical Chemistry |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Iron-Dependent Drug Delivery as a New Paradigm in Anti-Parasitic Chemotherapy and Prophylaxis |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Discovery of Novel Antimalarial Leads Targeting Translational Repression in Plasmodium parasites |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Identification of Novel Therapeutics Molecules against Old and New World Cutaneous Leishmaniasis |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Identification of Anti-HIV Lead Compounds Targeting |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Evolution and Inhibition of Serine Beta-Lactamase Activity |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Chemical Methods for Ferrous Iron Targeted Drug Delivery |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Identification of Novel Small Molecule Therapeutics for Visceral Leishmaniasis |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Chemical Methods for Ferrous Iron Dependent Drug Delivery |
Adam Renslo, PhD |
Department of Pharmaceutical Chemistry |
|
|
Regulation of the Development of Trypanosoma brucei |
|
Department of Pharmaceutical Chemistry |
|
|
Regulation of the Development of Tryanosoma brucei |
|
Department of Pharmaceutical Chemistry |
|
|
Purine Metabolism in Trichomonas Vaginalis |
|
Department of Pharmaceutical Chemistry |
|
|
Double-Stranded RNA Virus in Giardia |
|
Department of Pharmaceutical Chemistry |
|
|
Translation Regulation in Giardia lamblia |
|
Department of Pharmaceutical Chemistry |
|
|
Regulation of the Development of Trypanosoma brucei |
|
Department of Pharmaceutical Chemistry |
|
|
Selective Destruction of Cytochrome P450 by Drugs |
|
Department of Pharmaceutical Chemistry |
|
|
Creating Polyketide Antibiotic Diversity by Engineering Cytochrome P450 Enzymes / UC Discovery |
|
Department of Pharmaceutical Chemistry |
|
|
Hemoprotein Oxidation and Heme Catabolism |
|
Department of Pharmaceutical Chemistry |
|
|
Oxygen Sensors and P450 Monooxgenases in Mycobacterium tuberculosis |
|
Department of Pharmaceutical Chemistry |
|
|
Mechanism, Specificity, and Inhibition of Cytocchrome P450 |
|
Department of Pharmaceutical Chemistry |
|
|
Mechanism, Specificity, and Inhibition of Cytochrome P450 |
|
Department of Pharmaceutical Chemistry |
|
|
Hemoprotein Oxidation and Heme Catabolism |
|
Department of Pharmaceutical Chemistry |
|
|
Biochemistry and Hepatic Toxicity of Carbon Radicals |
|
Department of Pharmaceutical Chemistry |
|
|
Structure, Function and Inhibition of Beta-Lactamases |
|
Department of Pharmaceutical Chemistry |
|
|
Physics-Based Simulation of Biological Structures |
|
Department of Pharmaceutical Chemistry |
|
|
A Specific Mechanism for Non-Specific Inhibition |
|
Department of Pharmaceutical Chemistry |
|
|
A Web-Based Automatic Virtual Screening System |
|
Department of Pharmaceutical Chemistry |
|
|
International Collaboration in Chemistry: the Chemical Basis for Allosteric Regulation of G Protein Coupled Receptors |
|
Department of Pharmaceutical Chemistry |
|
|
Novel Therapeutics for Treatment of River Blindness and Lymphatic Filariasis |
Judy Sakanari, PhD |
IGHS Faculty Affiliate, Department of Pharmaceutical Chemistry |
|
|
Identification of Cobra-specific antibodies |
Charles Craik, PhD |
IGHS Faculty Affiliate, Department of Pharmaceutical Chemistry |
|
|